Portfolio company
Tissium
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Tissium develops light-activated programmable polymers for sutureless tissue reconstruction and nerve repair, providing these medical devices to surgeons and hospitals.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Silk Biomaterials
This company develops silk-based implantable medical devices for tissue regeneration, including nerve conduits and vascular grafts, for clinicians and patients requiring surgical repair.
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
NeoSurgical
The company develops laparoscopic instruments for surgeons to close port site incisions after abdominal surgery.
ROBOTIC MICROSURGERY
This company develops robotic surgical systems featuring miniaturised wristed instruments to assist surgeons in performing complex open microsurgery on delicate human tissues.
Klona Biotech
The company develops 3D-bioprinted structural human tissue implants, such as ligaments and tendons, for healthcare providers and patients requiring reconstructive surgery.
Mellon Medical
This company develops one-handed suturing devices for surgeons to perform precise wound closures in abdominal and vascular procedures.
Kuros Biosciences
This company develops bone graft technologies and orthobiologics for surgeons and hospitals to facilitate bone healing and tissue regeneration.
Novadip Biosciences
This company develops regenerative tissue products to treat patients with large bone defects, non-union fractures and spinal fusion requirements.
